Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system

• Bowen Wang,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Department of Rehabilitation Medicine, West China Second University Hospital, Sichuan University, Chengdu, China

  ⨯
• Zheyun Song,

  Roles Data curation, Formal analysis, Software

  Affiliation Xinxiang Medical University, Xinxiang, China

  ⨯
• Shan Lan,

  Roles Conceptualization, Project administration, Supervision

  Affiliation Sichuan Center for Food and Drug Evaluation, Inspection & Monitoring, SCFDA Adverse Drug Reaction Monitoring Center Medical Device Technology Review and Evaluation Center, Chengdu, China

  ⨯
• Xiubi Chen,

  Roles Data curation, Formal analysis, Visualization

  Affiliation Center for Adverse Drug Reaction Monitoring of Mianyang, Mianyang, China

  ⨯
• Xida Yan,

  Roles Data curation, Formal analysis, Visualization

  Affiliation Department of Pharmacy, Mianyang Central Hospital, Mianyang, China

  ⨯
• Xue-Feng Jiao

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Supervision, Validation, Writing – review & editing

  * E-mail: jiaoxuefenghx@163.com

  Affiliations Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University; Children’s Medicine Key Laboratory of Sichuan Province, Chengdu, China, NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu, China, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China

  https://orcid.org/0009-0000-7374-7226

  ⨯